Cushman & Wakefield Ltd. current report, 27 February 2020

Business Context and Reporting Period

This Form 8-K Current Report was filed by Cushman & Wakefield PLC on February 28, 2020, regarding events occurring on February 27, 2020. The filing focuses on executive leadership changes rather than periodic financial results.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It details the compensation package for a new executive appointment:

  • Annual Base Salary: $600,000
  • Annual Cash Incentive Award: Up to $900,000 (performance-based)
  • Long-Term Equity Incentives:
    • $1,320,000 in time-vesting Restricted Stock Units (RSUs) over four years
    • $880,000 in performance-vesting RSUs over three years
  • Severance: Twelve months' salary plus prorated cash incentive if terminated without cause

Material Changes

The primary material change is the appointment of Michelle MacKay as Chief Operating Officer (COO), effective April 6, 2020. Concurrently, Ms. MacKay will resign from the Company's board of directors. She brings prior experience as a Senior Advisor to iStar and Executive Vice President of Investments at iStar, as well as a senior role at UBS.

Guidance, Outlook, and Risks

The filing contains no specific financial guidance or outlook for the reporting period. It includes a standard cautionary note regarding forward-looking statements, highlighting risks such as global economic conditions, market changes, and government policy shifts. The document references the "Risk Factors" section of the Annual Report on Form 10-K for the year ended December 31, 2019, for additional details on potential uncertainties.

Investor Verification Checklist

  • Verify the commencement date of the new COO (April 6, 2020) and the effective date of the board resignation.
  • Review the attached press release (Exhibit 99.1) for further details on the appointment.
  • Consult the most recent Form 10-K for comprehensive risk factors and financial performance data not included in this 8-K.
  • Confirm the vesting schedules and performance criteria for the $2.2 million in equity grants.